Inventor
BERNOTAS RONALD CHARLES
US26 patents
⚠️ This page may combine multiple inventors who share the name “BERNOTAS RONALD CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WYETH CORP
22 patentsUS7259165B2Aug 21, 2007
Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP72 citations97
US7576087B2Aug 18, 2009
Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP29 citations92
US6727246B2Apr 27, 2004
1-(aminoalkyl)-3-sulfonylindole-and-indazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP29 citations92
US6995176B2Feb 7, 2006
1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP26 citations91
US7585876B2Sep 8, 2009
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP8 citations84
US6825212B2Nov 30, 2004
1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
WYETH CORP14 citations83
US7618990B2Nov 17, 2009
Oxazolidone derivatives as PR modulators
WYETH CORP9 citations82
US7238696B2Jul 3, 2007
Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
WYETH CORP12 citations82
US7297705B2Nov 20, 2007
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP8 citations73
US6800640B2Oct 5, 2004
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP9 citations73
US7291736B2Nov 6, 2007
Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands
WYETH CORP4 citations63
US7411064B2Aug 12, 2008
1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP3 citations62
US7057039B2Jun 6, 2006
1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP4 citations62
US7074792B2Jul 11, 2006
1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
WYETH CORP2 citations61
US7608717B2Oct 27, 2009
Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands
WYETH CORP0 citations52
US7589108B2Sep 15, 2009
1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP0 citations51
US7585873B2Sep 8, 2009
1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
WYETH CORP0 citations51
US7560470B2Jul 14, 2009
Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
WYETH CORP0 citations50
US7498327B2Mar 3, 2009
Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands
WYETH CORP1 citations48
US7544701B2Jun 9, 2009
Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligands
WYETH CORP0 citations42
US7618989B2Nov 17, 2009
Tricyclic oxazolidone derivatives useful as PR modulators
WYETH CORP0 citations40
US7538107B2May 26, 2009
Oxazinan-2-one derivatives useful as PR modulators
WYETH CORP0 citations40
AVENTIS PHARMA INC
2 patentsUS6716986B2Apr 6, 2004
Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-YL}-hydroxy-methyl)-2-methoxy-phenyl]ester
AVENTIS PHARMA INC3 citations58
US6465490B1Oct 15, 2002
Sulfuric acid mono-[3({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester
AVENTIS PHARMA INC3 citations58